... of blood biomarkers show promise as feasible adjunct tools to discriminate ICH from acute ischemic stroke in the field and have the potential for widespread accessibility. Key Messages: Ultra-early interventions in acute ICH are likely necessary to mitigate the risk of HME, and as such, the prehospital...

...Samuel D. Pettersson; Shunsuke Koga; Shan Ali; Alejandro Enriquez-Marulanda; Philipp Taussky; Christopher S. Ogilvy Introduction: This study aimed to elucidate mechanisms underlying moyamoya disease (MMD) pathogenesis and to identify potential novel biomarkers. We utilized gene co-expression...

...Barnaby J. Graff; Stephanie L. Harrison; Stephen J. Payne; Wahbi K. El-Bouri Background: Cerebral blood flow is known to decline with increasing age and is a potential biomarker to distinguish between healthy and unhealthy ageing, where healthy ageing is defined as an absence of comorbidities...

... was to determine whether the role of novel plasma biomarkers for atherosclerotic carotid artery disease is different in subjects developing symptomatic carotid artery stenosis (CAS), as opposed to those with incident asymptomatic CAS. Methods: The following biomarkers were measured in 5,550 middle-aged subjects...

... spontaneously or after thrombolysis in acute ischemic stroke (AIS) and can increase morbidity and mortality. The association of biomarkers with the risk of HT has been variably reported. We conducted a systematic review of the literature and meta-analysis and sought to compare blood biomarkers associated...

... significant. Inflammation Transient ischaemic attack Biomarkers Carotid stenosis Carotid atherosclerosis Despite high rates of treatment with modern secondary prevention agents, the 5-year risk of recurrent stroke and coronary events after ischaemic stroke and transient ischaemic attack (TIA...

... to in the content or advertisements. Acute ischemic stroke Endovascular thrombectomy Futile recanalization Early complication Biomarkers Endovascular thrombectomy (EVT) is a safe and effective treatment for acute ischemic stroke (AIS) caused by intracranial large vessel occlusion (LVO) in anterior...

... non-radiological biomarkers for END. Summary: Electronic searches from January 1990 to March 2017 identified studies reporting a blood/cerebrospinal fluid (CSF)/urine biomarker measurement within 24 h of acute stroke and at least 2 serial assessments of clinical neurological status (< 24 h...

...Wei Wang; Dong-Bin Li; Ru-Ying Li; Xia Zhou; Dong-Ju Yu; Xiao-Yan Lan; Jin-Pin Li; Jing-Li Liu Background: Early and accurate diagnosis of ischaemic stroke (IS) requires the use of an optimized biomarker. Exosomal microRNAs have the potential to serve as biomarkers owing to their stability...

..., instructions or products referred to in the content or advertisements. Matrix metalloproteinases Epidemiology Acute stroke Biomarkers Confounding Bias MMP-2 and MMP-9 samples in the SC were taken in the mornings (around 8:00 a.m.), a median of 21:00 h after stroke onset (IQR 15:38-25:15 h...

... troponin is elevated. Despite these recommendations, clinical decision making remains challenging in the setting of stroke and simultaneous troponin elevation. Some of these patients may have elevated cardiac biomarkers related to hyperadrenergic tone or other noncardiac sources, while others may have...

... and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. aging alzheimer's disease amyloid angiopathy biomarkers bleeding blood pressure brain hemorrhage Brain Imaging...

...) are the same as traditional risk factors for cerebrovascular disease (CVD). Early identification of subjects at higher risk of VCI is important for the development of effective preventive strategies. In addition to traditional vascular risk factors (VRF), circulating biomarkers have emerged as potential tools...

... of biomarkers of fatty acid intake with stroke. The aim of this study was to explore which individual plasma fatty acids would be associated with higher risk of ischemic stroke among whites. Methods: We studied 3,870 white men and women from the Minneapolis field center of the Atherosclerosis Risk...

.... The use of prognostic blood biomarkers could aid in decision-making processes, e.g. admitting patients to specialized stroke units. Although the prognostic role of natriuretic peptides has been studied in heart failure and coronary diseases, the value of brain natriuretic peptide (BNP) is less known...

... to damaging and reparative processes that follow acute stroke. Hypothermia Reperfusion Stem cell therapy Stroke Biomarkers Cerebral reorganization Immunology © 2012 S. Karger AG, Basel 2012 Copyright / Drug Dosage / Disclaimer Copyright: All rights reserved. No part...

... and poor prognosis with biomarkers might help to initiate adequate therapies and guide treatment decisions. Acute injury of the central nervous system, including stroke, disturbs the normally well-balanced interplay between the sympathetic nervous system and the immune system, thereby impairing...

... subtype Biomarkers Coagulation D-dimers Several studies have demonstrated differences in coagulation and fibrinolysis markers between various ischemic stroke subtypes [ 1,2,3,4,5,6,7,8,9,10 ]. One difference between atherothrombotic and cardioembolic stroke is the duration from thrombus...

...Mar Castellanos; Joaquín Serena Cerebral ischemia results in the activation of a cascade of molecular events as a result of which several substances with the potential characteristics of biomarkers are released into the peripheral blood. Although still in the research phase, the analysis...